1. Home
  2. PDEX vs SGMT Comparison

PDEX vs SGMT Comparison

Compare PDEX & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$55.79

Market Cap

197.4M

Sector

Health Care

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$6.99

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
SGMT
Founded
1978
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4M
169.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PDEX
SGMT
Price
$55.79
$6.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$56.00
$26.13
AVG Volume (30 Days)
87.1K
1.3M
Earning Date
05-01-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
345.00
N/A
EPS
3.27
N/A
Revenue
$66,593,000.00
$2,000,000.00
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.72
N/A
Revenue Growth
23.68
N/A
52 Week Low
$23.52
$4.50
52 Week High
$68.99
$10.46

Technical Indicators

Market Signals
Indicator
PDEX
SGMT
Relative Strength Index (RSI) 42.53 47.42
Support Level $55.29 $7.04
Resistance Level $55.62 $7.39
Average True Range (ATR) 3.23 0.44
MACD -0.56 -0.08
Stochastic Oscillator 23.81 21.77

Price Performance

Historical Comparison
PDEX
SGMT

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: